SMTL ID : 8riy.1

Human NUDT5 with ibrutinib derivative

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.29 Å

Oligo State

homo-dimer

Ligands

2 x W0O: 1-(1-methylpiperidin-4-yl)-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-4-amine

W0O.1: 9 residues within 4Å: Chain A: W.29, R.52, D.61, S.138, N.139, C.140 Chain B: W.47, E.48, G.136 9 PLIP interactions: 5 interactions with chain B, 4 interactions with chain A Hydrogen bonds: B:E.48, B:E.48 pi-Stacking: B:W.47, B:W.47, B:W.47, A:W.29, A:W.29, A:W.29 Hydrophobic interactions: A:W.29 W0O.2: 12 residues within 4Å: Chain A: W.47, E.48, G.136, L.137 Chain B: W.29, V.50, K.51, R.52, D.61, S.138, N.139, C.140 11 PLIP interactions: 6 interactions with chain A, 5 interactions with chain B Hydrophobic interactions: A:L.137, B:W.29, B:W.29, B:R.52 Hydrogen bonds: A:E.48, A:E.48 pi-Stacking: A:W.47, A:W.47, A:W.47, B:W.29, B:W.29

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Balikci, E. et al., Unexpected Noncovalent Off-Target Activity of Clinical BTK Inhibitors Leads to Discovery of a Dual NUDT5/14 Antagonist. J.Med.Chem. (2024)

Release Date

2024-05-01

Peptides

ADP-sugar pyrophosphatase: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
AAA

B
BBB

ADP-sugar pyrophosphatase

Related Entries With Identical Sequence